Biodegradable Polyesters with NSAID Pendant Groups for Controlled Drug Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current drug delivery systems for non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen suffer from low drug loadings, uncontrolled release, and use of non-biodegradable materials, leading to severe gastrointestinal side effects and short duration of action.

Innovation Solution

Development of biodegradable polyesters with NSAIDs as pendant groups, synthesized using tin (II) 2-ethylhexanoate as catalyst, which release the drugs in a controlled manner and are cytocompatible, reducing side effects and extending drug duration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If high and repeated systemic doses of NSAIDs are administered to treat long-lasting pain and inflammation, then the duration of drug effect is extended, but severe gastrointestinal side effects occur

Engineering Contradiction:
Improveduration of drug effectVSAvoidgastrointestinal side effects
Core Design Contradiction:
Duration of action of moving objectVSObject-affected harmful factors

Solution Approach 1:

The patent segments the drug delivery process by using biodegradable polyester particles that release NSAIDs gradually over time. The polymer matrix is divided into segments that erode progressively, controlling drug release rate and duration while maintaining localized concentration at the injection site, thereby extending drug effect without requiring repeated high systemic doses that cause GI side effects

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The biodegradable polyester acts as an intermediary carrier between the NSAID and the biological system. This intermediary material controls drug release kinetics through its degradation rate, providing sustained delivery while protecting the drug from rapid systemic distribution. The polyester matrix mediates between the need for prolonged action and the need to minimize harmful effects by maintaining controlled local concentrations

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of moving object

If drug delivery systems are used to control drug release and prolong duration of effect, then the duration of action is extended, but the systems suffer from low drug loadings and uncontrolled burst release

Engineering Contradiction:
Improveduration of drug effectVSAvoiddrug loading
Core Design Contradiction:
Duration of action of moving objectVSQuantity of substance

Solution Approach 1:

The patent merges the NSAID molecules directly into the polyester polymer chain structure through covalent bonding. The drug is incorporated as pendant groups or integrated into the repeating units of the polymer, achieving high drug loading (65-75% by weight). This merging approach eliminates the need for separate drug-polymer mixtures and provides controlled release without burst effect, as the drug is released only through systematic degradation of the polymer matrix

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention creates a composite material system where the NSAID and polyester form an integrated structure. The composite consists of the polymer backbone with drug molecules incorporated throughout, creating a homogeneous material with high drug content. The composite structure allows controlled degradation and release, avoiding burst release while achieving high drug loading capacity

Inventive Principle:
Principle #40Composite materials

3Duration of action of moving object

If conventional drug delivery systems are used, then prolonged drug action is achieved, but non-biodegradable materials are used requiring surgical removal

Engineering Contradiction:
Improveduration of drug effectVSAvoidease of removal
Core Design Contradiction:
Duration of action of moving objectVSEase of manufacture

Solution Approach 1:

The patent changes the key parameter of polymer degradability from non-biodegradable to biodegradable. The polyester is designed with hydrolyzable ester bonds that break down in physiological conditions, transforming the material from permanent to temporarily functional. This parameter change allows the system to provide prolonged drug action (weeks to months) while automatically degrading into harmless byproducts that are easily eliminated by the body, eliminating the need for surgical removal

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The biodegradable polyester delivery system functions as a disposable, temporary implant that serves its purpose and then naturally disappears. The material is designed to be short-lived in the biological sense, degrading completely after delivering the drug over the intended period. This eliminates the need for permanent implants that require surgical removal, making the system easier to manufacture and deploy without complex retrieval procedures

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The biodegradable polyesters achieve higher drug loadings (65-75%) with controlled and tunable release profiles, minimizing gastrointestinal side effects and providing prolonged drug action, while maintaining the chemical structure and bioactivity of the released NSAIDs.

Implementation Method 1

biodegradable polyesters...which release the drugs in a controlled manner

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

synthesized using tin (II) 2-ethylhexanoate as catalyst

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS9144579B2Polyesters and methods of use thereof
Publication Date: 2015.09.29 RUTGERS THE STATE UNIV
  • US9144579B2 patent drawing
  • US9144579B2 patent drawing
  • US9144579B2 patent drawing

AI summary

The invention provides polymers and methods for the treatment of pain and inflammation.